Donna M Tosh

发表

Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP142) administered intramuscularly with adjuvant system AS01

W. Otieno, L. Otieno, Nekoye Otsyula, 2013, Malaria Journal.

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults

Linda A. Murray, N. Waters, E. Jongert, 2020, The Journal of infectious diseases.

An open label study of the safety and efficacy of a single dose of weekly chloroquine and azithromycin administered for malaria prophylaxis in healthy adults challenged with 7G8 chloroquine-resistant Plasmodium falciparum in a controlled human malaria infection model

P. Waterman, J. Moon, J. Livezey, 2020, Malaria Journal.

An Open Label Study of the Safety and Efficacy of a Single Dose of Weekly Chloroquine and Azithromycin Administered for Malaria Prophylaxis in Healthy Adults Challenged with 7G8 Chloroquine-Resistant Plasmodium falciparum in a Controlled Human Malaria Infection (CHMI) Model

P. Waterman, J. Moon, J. Livezey, 2020 .

Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.

J. Dumler, A. Magill, Bryan L. Smith, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

Sumana Chakravarty, Joana C. Silva, S. Hoffman, 2017, JCI insight.

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy

Joshua D. Hartzell, W. Ballou, Joe D. Cohen, 2016, PLoS neglected tropical diseases.

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity

D. Carucci, Awalludin Sutamihardja, A. J. McCoy, 2013, PloS one.

Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

W. Ballou, Joe D. Cohen, E. Jongert, 2015, PloS one.

Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.

W. Mccarthy, C. Ockenhouse, J. Bennett, 2013, The New England journal of medicine.

Plasmodium falciparum infection during suppressive prophylaxis with mefloquine does not induce an antibody response to merozoite surface protein-1(42).

A. Magill, J. Moon, R. Miller, 2011, The American journal of tropical medicine and hygiene.

Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens

D. Chattopadhyay, E. Bergmann-Leitner, E. Angov, 2018, Infection and Immunity.

Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population

N. Waters, W. Mccarthy, Qigui Li, 2019, The Journal of infectious diseases.

Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

W. Ballou, E. Jongert, M. Lievens, 2015, PloS one.